The PennZone

  • Home
  • Business
  • Health
  • Financial
  • Construction
  • Arts
  • Music
  • Entertainment
  • Automotive

Peer-Reviewed Study Shows Measurable Impact on Employee Health and Productivity from Employee Assistance Program
The PennZone/10194774

Trending...
  • U.S. Entrepreneur Anjo De Heus Builds Innovation Bridge Between America and the Gulf
  • Veterans Day 2025: Honoring Service Through Storytelling
  • CCHR Supports Call to End Coercive Psychiatry at World Mental Health Congress
CuraLinc Healthcare
Five-year longitudinal analysis finds 84 percent of employees with depression and 78 percent with alcohol use concerns migrated to low- or no-risk after EAP treatment.

CHICAGO - PennZone -- To many employers, the value of an employee assistance program (EAP) is based on the understanding that employees with unresolved mental health, substance use and emotional wellbeing concerns often have troubles in their professional and personal lives that ultimately impact the organization's bottom line. Historically, EAPs and other workplace mental health providers have used a variety of metrics to illustrate their ability to resolve or mitigate these concerns, such as employee utilization, referrals to external resources, satisfaction surveys or website usage. While these measurements are effective and valuable tools that help employers evaluate the reach of the program, they don't truly measure the impact of the program on employee health, wellbeing and productivity.

New research published in the International Journal of Scientific and Research Publications (Volume 12, Issue 8, August 2022) reinforces how CuraLinc's unique approach to workplace mental health drives meaningful and lasting behavior change that leads to a decrease in absenteeism, an increase in productivity and improved health outcomes for employees who present with depression or alcohol use.

Depression
  • 84% of employees with depression recovered after EAP treatment to no longer be at-risk.
  • Only 12% of participants with depression were in a high-risk range after using the EAP, compared to 60% prior to participating in the program.
Productivity
  • 34% of participants had a work productivity problem prior to using the EAP, dropping to 5% after treatment.
  • Seven out of eight at-risk cases (88%) recovered to no longer have a work productivity problem after using the program.
Absenteeism
  • The average time missed from work due to the employee's presenting concern dropped from 9.0 hours during the initial assessment to 1.8 hours after using the program.
  • Half of EAP users (51%) had zero absences during the month before starting counseling, rising to 91% after completing treatment.
Alcohol Use
  • At the start of counseling, 66% of employees who presented with alcohol use as a primary or secondary concern were initially classified as risky drinkers or at a more severe level of alcohol misuse, but after counseling, only 14% of cases were at-risk.
  • After EAP treatment, 86% of employees were no longer at risk for alcohol misuse.

The aforementioned results were an excerpt from a peer-reviewed analysis of 33,683 EAP cases that originated between July 2017 and June 2022. Although data was collected from all participants, including spouses and dependents, only results from covered employees of CuraLinc clients were used in the data set.

More on The PennZone
  • ZEELOOL's Black Friday Sale Starts Early with Up to 80% Off Frames
  • UV Weathering Test Chamber vs Xenon Arc Test Chamber: What's the Right Solution for Your Products
  • Emeritus Addresses Hospital Bed Shortages with Smart Storage Solutions
  • Fulton County & Grow Your World Amplify Atlanta Youth Through the Youth Audio Collective
  • 2026 Oscars Betting Odds: One Battle After Another Favored for Best Picture

CuraLinc used the following clinically validated instruments to measure data from EAP participants.
  • Stanford Presenteeism Scale (SPS-6): Productivity
  • Workplace Outcomes Suite (WOS): Absenteeism
  • Patient Health Questionnaire (PHQ-9): Depression
  • Alcohol Use Disorders Identification Test (AUDIT): Alcohol Use

CuraLinc offered the SPS-6 and WOS to all employees; and offered the PHQ-9 and AUDIT to employees who presented with depression and alcohol abuse, respectively. After the assessment, CuraLinc followed up at the 30-day mark to measure changes in the employee's health and productivity, as well as their satisfaction with the EAP.

"Of the metrics available to help employers evaluate a workplace mental health program, one group stands above the rest – health and productivity outcomes," said CuraLinc's Senior Vice President of Administration, David Pawlowski, LCPC, CEAP, SAP. "Year after year, our program drives positive and measurable outcomes that impact not only job performance, but also the overall quality of life for employees who use the program."

About CuraLinc Healthcare

CuraLinc Healthcare, headquartered in Chicago, provides transformative mental health care fueled by connectivity – marrying technology and personalized advocacy to engage, empower and support employees throughout their care journey.  For more information, please call 800.490.1585, email info@curalinc.com or visit curalinc.com. Additional details regarding this study can also be found at IJSRP.org and at EAPOutcomes.com.

More on The PennZone
  • Allen Field Co., Inc. Components Selected for Esko ArtiosCAD 3D Component Library
  • Thirteen Reasons Why Gyminny Kids Is San Diego's Best Gymnastics Gym
  • Heritage At Manalapan - A New Luxury Single Family Home Community Coming Late 2025
  • The Lashe® Announces Exclusive November Savings for Lash and Beauty Professionals
  • Corcoran DeRonja Real Estate Welcomes Siobhán Simões to Its Growing Team

Contact
CuraLinc Healthcare
***@curalinc.com


Source: CuraLinc Healthcare
Filed Under: Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Cartwheel Signs Letter of Intent to License Clearsight Therapeutics' Novel Pink Eye Treatment for 2027 Portfolio Expansion
  • Vet Maps Launches National Platform to Spotlight Veteran-Owned Businesses and Causes
  • Diamond Wealth Advisors Experience the New York Stock Exchange and Ring the Closing Bell
  • $114.6 Million in Revenues, Up 54%: Uni-Fuels Holdings (N A S D A Q: UFG) Accelerates Global Expansion Across Major Shipping Hubs as Demand Surges
  • Dental Care Solutions Unveils New Website for Enhanced Patient Engagement
  • TradingHabits.com Launches to Support Day Trader Well-being
  • $750 Million Market on Track to $3.35 Billion by 2034: $NRXP Launches First-in-Florida "One Day" Depression Treatment in Partnership with Ampa Health
  • SMS Launches Real-Time Fiber-Optic Monitoring for Critical Infrastructure
  • $750 Million Market Set to Soar to $3.35 Billion by 2034 as Florida Launches First-in-Nation One-Day: NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP
  • LATO AI Tailors AI-Powered Appointment Booking System for Custom Clothing Designer David Alan
  • BITE Data raises $3m to build AI tools for global trade compliance teams
  • Phinge Issues Notice of Possible Infringement, Investigates App-less AI Agents & Technology for Unauthorized Use of its Patented App-less Technologies
  • Huntington Learning Center of Russellville Marks 1 Year Anniversary; Extends Reduced Grant-Aligned Rates to All Students in Learning Center Services
  • CCHR Supports Call to End Coercive Psychiatry at World Mental Health Congress
  • purelyIV Expands Wellness Services with Flu/COVID Testing and Menopause Coaching & Treatment
  • WHES Retains BloombergNEF Tier 1 Ranking for Sixth Consecutive Quarter
  • U.S. Entrepreneur Anjo De Heus Builds Innovation Bridge Between America and the Gulf
  • UK Financial Ltd Confirms All 8 Mexican Gold Mines Exist — Audited and Backing UKFL's Ecosystem With Double the 2018 Gold Value
  • Veterans Day 2025: Honoring Service Through Storytelling
  • Kaltra Offers Microchannel Condensers Optimized for Low-GWP Refrigerants R454B, R32, and R290

Popular on PennZone

  • New Article by Roy J. Meidinger – Examines Hidden Hidden Healthcare Kickbacks - 408
  • Some Music for Donald's Bad Day
  • Mensa Foundation's New Science Program Encourages Hands-On Discovery
  • Hiclean Tools Releases HCX2100 Electric Pressure Washer
  • Investing in Greece: Your Definitive Real-Estate FAQ Guide
  • GitKraken Launches Insights to Help Engineering Leaders Quantify AI Impact and Improve Developer Experience
  • Blogging Pioneer Sherry Bennett Celebrates 29 Years Online - From College Blogger to Successful Entrepreneur
  • Why Philadelphia Homeowners Should Ditch Oil for Natural Gas
  • 'Wild Hermit Wellness' Has Achieved Bestseller Status in Just 2 Months Since Launch Of Organic Skincare Line
  • Crypto Betting Odds 2025: Bookmakers Review Analyzes Market Predictions and Year-End Price Lines

Similar on PennZone

  • Emeritus Addresses Hospital Bed Shortages with Smart Storage Solutions
  • Fulton County & Grow Your World Amplify Atlanta Youth Through the Youth Audio Collective
  • November is Lung Cancer Awareness Month: Screening Saves Aims to Increase Access to Lung Screenings in NC
  • Valeo Health Leads a New Era of Longevity and Preventive Health in the UAE
  • 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone
  • Cartwheel Signs Letter of Intent to License Clearsight Therapeutics' Novel Pink Eye Treatment for 2027 Portfolio Expansion
  • Dental Care Solutions Unveils New Website for Enhanced Patient Engagement
  • TradingHabits.com Launches to Support Day Trader Well-being
  • $750 Million Market on Track to $3.35 Billion by 2034: $NRXP Launches First-in-Florida "One Day" Depression Treatment in Partnership with Ampa Health
  • $750 Million Market Set to Soar to $3.35 Billion by 2034 as Florida Launches First-in-Nation One-Day: NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us